These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33448876)

  • 1. North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative.
    Patel JN; Voora D; Bell G; Bates J; Cipriani A; Bendz L; Frick A; Hamadeh I; McGee AS; Steuerwald N; Imhof S; Wiltshire T
    Pharmacogenomics; 2021 Jan; 22(2):73-80. PubMed ID: 33448876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
    Rakhra-Burris TK; Auman JT; Deverka P; Dressler LG; Evans JP; Goldberg RM; Havener TM; Hoskins JM; Jonas DE; Long KM; Motsinger-Reif AA; Irvin WJ; Richards KL; Roederer MW; Valgus JM; Riper Mv; Vernon JA; Zamboni WC; Wagner MJ; Walko CM; Weck KE; Wiltshire T; McLeod HL
    Pharmacogenomics; 2010 Jan; 11(1):13-21. PubMed ID: 20017668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.
    Raccor BS; Thompson DK; Thomas C; Hill AK; Shields K; Alcala-Williams I; Cartrette T; Fasinu P; Al-Achi A
    Pharmacogenomics; 2021 Jan; 22(1):13-25. PubMed ID: 33356552
    [No Abstract]   [Full Text] [Related]  

  • 4. Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.
    Bastaki K; Velayutham D; Irfan A; Adnan M; Mohammed S; Mbarek H; Qoronfleh MW; Jithesh PV
    Front Public Health; 2024; 12():1364221. PubMed ID: 38550311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the Educational Environment of Genomics and Pharmacogenomics in the United Arab Emirates: A Mixed-Methods Triangulated Design.
    Rahma AT; Ahmed LA; Elsheik M; Elbarazi I; Ali BR; Patrinos GP; Al-Maskari F
    OMICS; 2021 May; 25(5):285-293. PubMed ID: 33904793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assuring access to dental care for low-income families in North Carolina. The NC Institute of Medicine Task Force Study.
    Silberman P; Wicker DA; Smith SH; DeFriese GH
    N C Med J; 2000; 61(2):95-8. PubMed ID: 10737031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of pharmacogenomics testing for precision medicine.
    Kanegusuku ALG; Chan CW; O'Donnell PH; Yeo KJ
    Crit Rev Clin Lab Sci; 2024 Mar; 61(2):89-106. PubMed ID: 37776898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming quality of care in North Carolina.
    Newton W; Bradley D
    N C Med J; 2013; 74(2):119-25. PubMed ID: 23802471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support.
    Qin W; Lu X; Shu Q; Duan H; Li H
    Pharmacogenomics; 2022 Jan; 23(1):35-48. PubMed ID: 34787504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PharmGKB: A worldwide resource for pharmacogenomic information.
    Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
    Scott SA; Owusu Obeng A; Botton MR; Yang Y; Scott ER; Ellis SB; Wallsten R; Kaszemacher T; Zhou X; Chen R; Nicoletti P; Naik H; Kenny EE; Vega A; Waite E; Diaz GA; Dudley J; Halperin JL; Edelmann L; Kasarskis A; Hulot JS; Peter I; Bottinger EP; Hirschhorn K; Sklar P; Cho JH; Desnick RJ; Schadt EE
    Pharmacogenomics; 2017 Oct; 18(15):1381-1386. PubMed ID: 28982267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prerequisites to implementing a pharmacogenomics program in a large health-care system.
    Levy KD; Decker BS; Carpenter JS; Flockhart DA; Dexter PR; Desta Z; Skaar TC
    Clin Pharmacol Ther; 2014 Sep; 96(3):307-9. PubMed ID: 24807457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing North Carolina's health care costs through environmental disease prevention.
    Gibson JM; Devlin L; Brown D; Armes M
    N C Med J; 2011; 72(2):119-24. PubMed ID: 21721497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.
    Krebs K; Milani L
    Hum Genomics; 2019 Aug; 13(1):39. PubMed ID: 31455423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary model to implement pharmacogenomics at the point of care.
    Caraballo PJ; Hodge LS; Bielinski SJ; Stewart AK; Farrugia G; Schultz CG; Rohrer-Vitek CR; Olson JE; St Sauver JL; Roger VL; Parkulo MA; Kullo IJ; Nicholson WT; Elliott MA; Black JL; Weinshilboum RM
    Genet Med; 2017 Apr; 19(4):421-429. PubMed ID: 27657685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using State Licensure Data to Assess North Carolina's Health Workforce COVID-19 Response Capacity.
    Wilson H; Galloway EM; Spero JC; Thomas S; Long JC; Ricketts TC; Fraher EP
    N C Med J; 2021; 82(1):29-35. PubMed ID: 33397751
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.